HomeCompareEXNN vs JNJ

EXNN vs JNJ: Dividend Comparison 2026

EXNN yields 49.88% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXNN wins by $371.5K in total portfolio value
10 years
EXNN
EXNN
● Live price
49.88%
Share price
$4.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$391.5K
Annual income
$79,179.78
Full EXNN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EXNN vs JNJ

📍 EXNN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXNNJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXNN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXNN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXNN
Annual income on $10K today (after 15% tax)
$4,239.40/yr
After 10yr DRIP, annual income (after tax)
$67,302.81/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, EXNN beats the other by $66,599.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXNN + JNJ for your $10,000?

EXNN: 50%JNJ: 50%
100% JNJ50/50100% EXNN
Portfolio after 10yr
$205.7K
Annual income
$40,003.78/yr
Blended yield
19.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EXNN
No analyst data
Altman Z
0.0
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXNN buys
0
JNJ buys
0
No recent congressional trades found for EXNN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXNNJNJ
Forward yield49.88%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$391.5K$20.0K
Annual income after 10y$79,179.78$827.78
Total dividends collected$312.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EXNN vs JNJ ($10,000, DRIP)

YearEXNN PortfolioEXNN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$15,688$4,987.53$10,676$355.77+$5.0KEXNN
2$24,098$7,312.34$11,407$389.39+$12.7KEXNN
3$36,283$10,497.82$12,198$426.53+$24.1KEXNN
4$53,594$14,771.81$13,056$467.62+$40.5KEXNN
5$77,738$20,392.43$13,987$513.12+$63.8KEXNN
6$110,824$27,644.06$14,998$563.56+$95.8KEXNN
7$155,413$36,831.29$16,098$619.52+$139.3KEXNN
8$214,563$48,271.03$17,295$681.69+$197.3KEXNN
9$291,865$62,283.09$18,599$750.82+$273.3KEXNN
10$391,476$79,179.78$20,022$827.78+$371.5KEXNN

EXNN vs JNJ: Complete Analysis 2026

EXNNStock

Exent Corp. focuses on developing, promoting, and executing integrated smart-home systems and solutions in the People's Republic of China. It was engages in the manufacturing and sales of drywall steel studs which were used in new developments, commercial, and residential construction and in home improvement, remodeling and repair work in Kyrgyzstan. The company was founded in 2017 and is based in Shenzhen, China.

Full EXNN Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EXNN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXNN vs SCHDEXNN vs JEPIEXNN vs OEXNN vs KOEXNN vs MAINEXNN vs ABBVEXNN vs MRKEXNN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.